Riskpilot← Back to searchSign inGet full accessUniBio Tech Science ApS
APSActiveCVR 33062796Slagkrogen 15Patent brokering and marketing service activities · NACE 7491Est. 20101 employees
Revenue 2024
DKK 7K
-105% vs 2023
EBITDA margin
-6108.8%
-190% vs 2023
Equity ratio
97.2%
Financial strength
Net profit 2024
DKK -815K
+51% vs 2023
| Revenue | DKK 7K | -105% |
| EBITDA | DKK -446K | -190% |
| Net profit | DKK -815K | +51% |
| Total assets | DKK 28,6M | -1% |
| Equity | DKK 27,8M | -3% |
| Employees | 1 | — |
Legal name
UniBio Tech Science ApS
CVR number
33062796
Legal form
Anpartsselskab
NACE code
7491 · Patent brokering and marketing service activities
Founded
5. juli 2010
Share capital
DKK 595.717
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af en direktør.
Company purpose
Selskabets formål er at besidde aktier, foretage investeringer samt anden dermed beslægtet virksomhed.
Address
Slagkrogen 15
Phone
+4521296974
Email
hbl@hblinvest.dk
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 281 | -79 | -42 | -74 | -76 | -174 | -117 | -143 | -117 | -528 | -364 | -154 | 7 |
| Staff expenses | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -392 | -0 | -401 |
| EBITDA | 255 | -79 | -42 | -74 | -76 | -174 | -117 | -143 | -117 | -585 | -756 | -154 | -446 |
| Depreciation & amort. | -0 | -0 | -0 | -0 | -0 | -15 | -102 | -222 | -210 | -168 | -368 | -1.515 | -842 |
| EBIT | 255 | -79 | -42 | -74 | -76 | -189 | -219 | -365 | -326 | -753 | -1.124 | -1.669 | -1.289 |
| Net financials | -1.377 | -821 | -135 | 18.717 | -86 | 2.166 | 24.249 | 91 | 12 | 459 | -314 | 149 | 394 |
| Profit before tax | -1.122 | -900 | -177 | 18.642 | -162 | 1.977 | 24.030 | -274 | -314 | -294 | -1.438 | -1.521 | -895 |
| Tax | 62 | 87 | 14 | -1 | -17 | -48 | 0 | -82 | -47 | -30 | -296 | 156 | -80 |
| Net profit | -1.184 | -988 | -191 | 18.644 | -145 | 2.025 | 24.029 | -192 | -267 | -265 | -1.142 | -1.677 | -815 |
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 3.280 | 1.552 | 1.807 | 20.510 | 20.497 | 25.308 | 49.007 | 46.019 | 43.575 | 32.757 | 32.773 | 28.845 | 28.569 |
| Equity | 2.280 | 1.383 | 1.788 | 20.431 | 20.286 | 22.174 | 45.793 | 45.721 | 43.454 | 32.671 | 30.451 | 28.657 | 27.780 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 1.000 | 169 | 19 | 79 | 211 | 3.134 | 3.214 | 299 | 121 | 86 | 2.322 | 189 | 788 |
| Total debt | 1.000 | 169 | 19 | 79 | 211 | 3.134 | 3.214 | 299 | 121 | 86 | 2.322 | 189 | 788 |
EBITDA margin
-6108.8%
This company
15.8%
Market median
-38763% vs market
20122024
Equity ratio
97.2%
This company
38.2%
Market median
+154% vs market
20122024
Return on equity
-2.9%
This company
18.4%
Market median
-116% vs market
20122024
Net profit margin
-11156.3%
This company
8.1%
Market median
-137832% vs market
20122024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20122024
Debt / equity
0.03×
This company
0.62×
Market median
+95% vs market
20122024
- Annual report 2024Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via CVR / Virk · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via CVR / Virk · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via CVR / Virk · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via CVR / Virk · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via CVR / Virk · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via CVR / Virk · Period 2015-01-01 – 2015-12-31
- Annual report 2014Filed via CVR / Virk · Period 2014-01-01 – 2014-12-31
- Annual report 2013Filed via CVR / Virk · Period 2013-01-01 – 2013-12-31
- Annual report 2012Filed via CVR / Virk · Period 2012-01-01 – 2012-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
HB Management | Management | 2024 | — | — |
EB Founder | Founder | 2010 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2022 | — | — | |
| Board of Directors | 2013 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Individual | 100.0% | 100.0% | 2024 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
UniBio Tech Science ApS 
GreenCow A/SBoard members of UniBio Tech Science ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Henrik Busch-Larsen | Management | 0 companies |
| Ebbe Bjerne Busch Larsen | Founder | 0 companies |
| Christen Jensen Sørensen | Board of Directors | 0 companies |
| Johan Thomsen | Board of Directors | 0 companies |